Market Place
Sourcing Support
Teva’s Generics Nintedanib Receives Tentative Approval in US
26 Mar 2026 //
FDA
Glenmark’ Generics Nintedanib Receives Tentative Approval in US
26 Mar 2026 //
FDA
Corcept Therap’s Lifyorlitm Receives Approval in Us
25 Mar 2026 //
FDA
Encube’s Generics Tretinoin Receives Approval in US
25 Mar 2026 //
FDA
Denali’s Biologics Avlayah Receives Approval in US
24 Mar 2026 //
FDA
Ascent Pharms’ Generics Guanfacine HCl Receives Approval in US
24 Mar 2026 //
FDA
Unique’s Generics Bisoprolol Fumarate Receives Approval in US
24 Mar 2026 //
FDA
Zhejiang Jingxin’s Generics Ticagrelor Receives Approval in US
24 Mar 2026 //
FDA
Macleods Pharms’ Generics Mexiletine HCl Receives Approval in US
23 Mar 2026 //
FDA
Rising’s Generics Clindamycin Phosphate Receives Approval in US
23 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Cefixime Receives Approval in US
23 Mar 2026 //
FDA
Map77’s Atoncy Receives Approval in US
20 Mar 2026 //
FDA
Quagen’s Generics Lidocaine HCl Receives Approval in US
20 Mar 2026 //
FDA
Viwit Pharm’s Generics Lidocaine HCl Receives Approval in US
19 Mar 2026 //
FDA
Freseni Kabi’s Generics Ephedrine Sulfate Receives Approval in US
19 Mar 2026 //
FDA
Amneal Pharms’s Kitprozy Receives Tentative Approval in US
19 Mar 2026 //
FDA
Micro’s Generics Valganciclovir HCl Receives Approval in US
19 Mar 2026 //
FDA
Deproco’s Flavalta Receives Approval in US
19 Mar 2026 //
FDA
I3 Pharms’ Generics Rifabutin Receives Approval in US
19 Mar 2026 //
FDA
Actavis’s Generics Rifaximin Receives Approval in US
19 Mar 2026 //
FDA
Natco’s Generics Palbociclib Receives Tentative Approval in US
19 Mar 2026 //
FDA
Annora’s Generics Desogestrel & Estradiol Receives Approval in US
18 Mar 2026 //
FDA
Aurobindo’s Generics Clindamycin Receives Approval in US
18 Mar 2026 //
FDA
Dr Reddy’s Generics Sugammadex Receives Tentative Approval in US
18 Mar 2026 //
FDA
Biocon’s Generics Cabozantinib Receives Tentative Approval in US
17 Mar 2026 //
FDA
Qilu’s Generics Nintedanib Receives Tentative Approval in US
17 Mar 2026 //
FDA
Aspiro’s Generics Micafungin Na Receives Approval in US
17 Mar 2026 //
FDA
Glaxosmithkline’s Lynavoy Receives Approval in US
17 Mar 2026 //
FDA
Janssen’s Icotyde Receives Approval in US
17 Mar 2026 //
FDA
Formosa’s Generics Eribulin Mesylate Receives Approval in US
16 Mar 2026 //
FDA
App’s Generics Acamprosate Calcium Receives Approval in US
16 Mar 2026 //
FDA
Glenmark`s Generics Fluticasone Receives Approval in US
16 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Citalopram Receives Approval in US
13 Mar 2026 //
FDA
Orbicular’s Generics Phytonadione Receives Approval in US
13 Mar 2026 //
FDA
Caplin’s Generics Potassium Phosphates Receives Approval in US
12 Mar 2026 //
FDA
Hetero’s Generics Promethazine HCl Receives Approval in US
12 Mar 2026 //
FDA
Gland’s Generics Brimonidine Tartrate Receives Approval in US
11 Mar 2026 //
FDA
Biocon’s Generics Liraglutide Receives Approval in US
11 Mar 2026 //
FDA
Zydus’ Generics Cevimeline HCl Receives Approval in US
11 Mar 2026 //
FDA
Humanwell’s Generics Desvenlafaxine Receives Approval in US
10 Mar 2026 //
FDA
Difgen Pharms’ Generics Mesalamine Receives Approval in US
10 Mar 2026 //
FDA
Apotex’s Generics Sitagliptin Receives Tentative Approval in US
10 Mar 2026 //
FDA
Strides’s Generics Milnacipran Receives Tentative Approval in US
09 Mar 2026 //
FDA
Steranco’s Generics Oxcarbazepine Receives Approval in US
09 Mar 2026 //
FDA
Contract Pharmacal’s Generics Famotidine Receives Approval in US
09 Mar 2026 //
FDA
Knack’s Generics Dexmedetomidine HCl Receives Approval in US
09 Mar 2026 //
FDA
Micro’s Generics Bisoprolol Fumarate Receives Approval in US
09 Mar 2026 //
FDA
E5 Pharma’s Generics Ivermectin Receives Approval in US
09 Mar 2026 //
FDA
Aphelion’s Pylarify Truvu Receives Approval in US
06 Mar 2026 //
FDA
Specgx’s Generics Tofacitinib Receives Tentative Approval in US
06 Mar 2026 //
FDA
Prinston’s Generics Gabapentin Receives Approval in US
06 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Siponimod Receives Approval in US
06 Mar 2026 //
FDA
Anthea Pharma’s Generics Olanzapine Receives Approval in US
05 Mar 2026 //
FDA
Rubin Research’s Generics Ibuprofen Receives Approval in US
05 Mar 2026 //
FDA
Annora Pharma’s Generics Paroxetine HCl Receives Approval in US
05 Mar 2026 //
FDA
Micro’s Generics Cholestyramine Receives Approval in US
05 Mar 2026 //
FDA
Mylan’s Generics Aprepitant Receives Approval in US
05 Mar 2026 //
FDA
Puracap’s Generics Nintedanib Receives Tentative Approval in US
05 Mar 2026 //
FDA
Laurus’s Generics Emtricitabine Receives Approval in US
04 Mar 2026 //
FDA
Aspiro’s Generics Rocuronium Bromide Receives Approval in US
04 Mar 2026 //
FDA
